您的位置:首页 > 产品中心 > JIM1
产品性质
biological source【生物来源】 | human blood |
growth mode【生长模式】 | Suspension |
karyotype【核型】 | Not specified |
morphology【形态学】 | Small spherical |
products【产品】 | Not specified |
receptors【受体】 | Not specified |
technique(s) | cell culture | mammalian: suitable |
relevant disease(s)【相关疾病】 | cancer |
shipped in【运输】 | dry ice |
基本信息
Cell Line Origin【细胞系来源】 | Human myeloma, cancer |
Cell Line Description【细胞系描述】 | JIM1 is a myeloma tumour line demonstrating typical plasma cell phenotype (CD38, PCA-1 8A and CD24 positive), deficient in DNA repair. JIM1 was derived from plasma myeloma cells derived from pleural fluid of advanced multiple myeloma patient, homoplastic with JIM3. |
DNA Profile【DNA图谱分析】 | Not specified |
Culture Medium【培养基】 | Dexter culture medium, consisting of Fischer′s medium + 20% FCS +10-7 M hydrocortisone sodium succinate. |
Subculture Routine【传代培养常规】 | Seed at 2-9 x 10 5 cells/cm3 5% CO2; 37 ℃. |
Other Notes【其他说明】 | Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information. |
产品说明
Disclaimer【免责声明】 | This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form. |